Evidence map›Paper›PMID 35743048›Full record

ArticleInternational journal of molecular sciences2022

Application of Sensitivity Analysis to Discover Potential Molecular Drug Targets.

Malgorzata Kardynska, Jaroslaw Smieja, Pawel Paszek, Krzysztof Puszynski

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Mathematical Modeling Support for Lung Cancer Therapy-A Short Review.International journal of molecular sciences · 2023
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Malgorzata KardynskaDepartment of Biosensors and Processing of Biomedical Signals, Silesian University of Technology, 41-800 Zabrze, Poland.ORCID 0000-0003-4858-5266
Jaroslaw SmiejaDepartment of Systems Biology and Engineering, Silesian University of Technology, 44-100 Gliwice, Poland.ORCID 0000-0002-6120-4424
Pawel PaszekSchool of Biology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, UK.ORCID 0000-0002-0363-0716
Krzysztof PuszynskiDepartment of Systems Biology and Engineering, Silesian University of Technology, 44-100 Gliwice, Poland.ORCID 0000-0002-5546-4916

Funding

Biotechnology and Biological Sciences Research Council BB/I017976/1National Science Center 2016/21/B/ST7/0224 (PP)National Science Center DEC--2016/23/B/ST6/03455 (KP)Silesian University of Technology 02/040/BK_22/1022 (JS)Silesian University of Technology 07/040/BK_22/101 (MK)
6 · The paper itself

Abstract

Mathematical modeling of signaling pathways and regulatory networks has been supporting experimental research for some time now. Sensitivity analysis, aimed at finding model parameters whose changes yield significantly altered cellular responses, is an important part of modeling work. However, sensitivity methods are often directly transplanted from analysis of technical systems, and thus, they may not serve the purposes of analysis of biological systems. This paper presents a novel sensitivity analysis method that is particularly suited to the task of searching for potential molecular drug targets in signaling pathways. Using two sample models of pathways, p53/Mdm2 regulatory module and IFN-β-induced JAK/STAT signaling pathway, we show that the method leads to biologically relevant conclusions, identifying processes suitable for targeted pharmacological inhibition, represented by the reduction of kinetic parameter values. That, in turn, facilitates subsequent search for active drug components.

Indexed as

Models, BiologicalSignal TransductionKineticsbioinformaticschemotherapymolecular drug targetssensitivity analysissystems biology

Identifiers

PMID35743048
PMCPMC9223434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.